Breaking News Instant updates and real-time market news.

2019-11-04 07:28:08 NTRA Natera $38.94 0.42 (1.09%) 07:28 11/04/19 11/04 07:28 11/04/19 07:28	Natera price target raised to $32 from $27 at JPMorgan JPMorgan analyst Tycho Peterson raised his price target for Natera to $32 from $27 after completing a survey on the U.S. kidney transplant rejection monitoring market. He says that given the recent excitement around liquid biopsy and Natera's Signatera test for recurrence monitoring, he now believes Prospera is an underappreciated opportunity for the company in investor estimates. Peterson keeps a Neutral rating on Natera shares.	06 Nov
NTRA Natera $38.94 0.42 (1.09%) 09/24/19 PIPR 09/24/19 NO CHANGE Target $45 PIPR Overweight Natera price target raised to $45 from $32 at Piper Jaffray Piper Jaffray analyst William Quirk said Natera's partnership with Foundation Medicine for the Signatera assay complements Natera's own direct channels and broadens the utility of the assay to late stage cancers. The analyst, who also thinks the deal increases Natera's access to large customer groups, increased his price target on Natera shares to $45 from $32 and keeps an Overweight rating on the stock. 10/11/19 PIPR 10/11/19 NO CHANGE Target $45 PIPR Overweight Natera oncology opportunity 'remains strong,' says Piper Jaffray Piper Jaffray analyst William Quirk keeps an Overweight rating on Natera with a $45 price target after the company hosted a conference call to discuss its oncology offering. Management has a clear plan to access the oncology market via partnerships with Foundation Medicine and BGI, and their own direct channels, Quirk tells investors in a research note partially titled "Oncology Opportunity Remains Strong". The analyst estimates the initial Signatera market opportunity for colorectal cancer is ~$4.4B. While smaller than his initial expectations, Quirk continues to believe the long-term opportunity "remains robust" as Natera expands the assay to other cancers and gains traction with clinical and pharma customers. 10/18/19 COWN 10/18/19 NO CHANGE Target $42 COWN Outperform Natera price target raised to $42 from $30 at Cowen Cowen analyst Doug Schenkel raised his price target on Natera to $42 from $30 following the company's preannouncement of Q3 results which were ahead of expectations. The analyst updated his model to account for recent positive developments, updates on Signatera and Prospera, and to take a more conservative outlook for average-risk NIPT. Schenkel reiterated his Outperform rating on Natera shares. 10/22/19 PIPR 10/22/19 NO CHANGE Target $45 PIPR Overweight Natera has 'significant opportunity' in oncology, says Piper Jaffray Piper Jaffray analyst William Quirk estimates Natera has a $12.8B market opportunity for Signatera in bladder, breast, colon, and lung cancer. This is somewhat comparable with management's $15B estimate of the oncology molecular residual disease market opportunity, Quirk tells investors in a research note. The analyst continues to believe oncology represents a "significant opportunity" for Natera. He reiterates an Overweight rating on the shares with a $45 price target.

2019-11-04 07:28:08

NTRA

Natera

$38.94: 0.42 (1.09%)

07:28

11/04/19

11/04

07:28

11/04/19

07:28

Natera price target raised to $32 from $27 at JPMorgan

JPMorgan analyst Tycho Peterson raised his price target for Natera to $32 from $27 after completing a survey on the U.S. kidney transplant rejection monitoring market. He says that given the recent excitement around liquid biopsy and Natera's Signatera test for recurrence monitoring, he now believes Prospera is an underappreciated opportunity for the company in investor estimates. Peterson keeps a Neutral rating on Natera shares.

06
Nov

NTRA Natera

$38.94: 0.42 (1.09%)

09/24/19: PIPR

10/11/19: PIPR

10/18/19: COWN

10/22/19: PIPR

TODAY'S FREE FLY STORIES

THS TreeHouse $50.86 0.155 (0.31%) 08:08 12/06/19 12/06 08:08 12/06/19 08:08 Conference/Events	TreeHouse to host investor meeting » Investor breakfast… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial 03/08/13 Wedge Partners 03/08/13 Credit Suisse 03/06/13 Citigroup 03/06/13 Barclays See Street Research during your Free Trial	10 Dec
PSMT PriceSmart $74.03 1.095 (1.50%) 08:08 12/06/19 12/06 08:08 12/06/19 08:08 Hot Stocks	PriceSmart opens new warehouse club in Guatemala City, Guatemala » PriceSmart announced that… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in in 9 minutes Get Free Trial 03/08/13 Wedge Partners 03/08/13 Credit Suisse 03/06/13 Citigroup 03/06/13 Barclays See Street Research during your Free Trial
PSMT PriceSmart $74.03 1.095 (1.50%) 08:07 12/06/19 12/06 08:07 12/06/19 08:07 Hot Stocks	PriceSmart reports November net merchandise sales up 7.5% to $278.3M » PriceSmart announced that… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial 03/08/13 Wedge Partners 03/08/13 Credit Suisse 03/06/13 Citigroup 03/06/13 Barclays See Street Research during your Free Trial
KTOS Kratos Defense $17.20 0.05 (0.29%) 08:06 12/06/19 12/06 08:06 12/06/19 08:06 Hot Stocks	Kratos awarded $39M sole-source contract for RF signal communication services » Kratos Defense &… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in in 9 minutes Get Free Trial 03/08/13 Wedge Partners 03/08/13 Credit Suisse 03/06/13 Citigroup 03/06/13 Barclays See Street Research during your Free Trial
JILL J.Jill $1.22 -0.49 (-28.66%) 08:06 12/06/19 12/06 08:06 12/06/19 08:06 Downgrade	J.Jill rating change » Jefferies downgrades… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial 03/08/13 Wedge Partners 03/08/13 Credit Suisse 03/06/13 Citigroup 03/06/13 Barclays See Street Research during your Free Trial

AZUL Azul $38.17 0.33 (0.87%) 08:05 12/06/19 12/06 08:05 12/06/19 08:05 Hot Stocks	Azul reports November traffic up 30.6%, capacity up 32.5% » Load factor was 82.4%,… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in in 9 minutes Get Free Trial 03/08/13 Wedge Partners 03/08/13 Credit Suisse 03/06/13 Citigroup 03/06/13 Barclays See Street Research during your Free Trial
FGP Ferrellgas Partners $0.57 -0.024 (-4.07%) 08:04 12/06/19 12/06 08:04 12/06/19 08:04 Earnings	Ferrellgas Partners reports Q1 EPS (46c), one est. (35c) » Reports Q1 revenue… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial 03/08/13 Wedge Partners 03/08/13 Credit Suisse 03/06/13 Citigroup 03/06/13 Barclays See Street Research during your Free Trial
SATS EchoStar $39.76 0.36 (0.91%) 08:03 12/06/19 12/06 08:03 12/06/19 08:03 Hot Stocks	Yahsat and Hughes launch satellite services joint venture in Brazil » Hughes Network Systems… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in in 9 minutes Get Free Trial 03/08/13 Wedge Partners 03/08/13 Credit Suisse 03/06/13 Citigroup 03/06/13 Barclays See Street Research during your Free Trial
BHAT Blue Hat Interactive $2.72 -0.01 (-0.37%) 08:02 12/06/19 12/06 08:02 12/06/19 08:02 Hot Stocks	Blue Hat signs LOI to acquire controlling interest in Fuzhou Csfctech Co. » Blue Hat Interactive… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial 03/08/13 Wedge Partners 03/08/13 Credit Suisse 03/06/13 Citigroup 03/06/13 Barclays See Street Research during your Free Trial
HOME At Home Group $5.48 -3.07 (-35.91%) 08:02 12/06/19 12/06 08:02 12/06/19 08:02 Downgrade	At Home Group rating change » At Home Group downgraded… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in in 9 minutes Get Free Trial 03/08/13 Wedge Partners 03/08/13 Credit Suisse 03/06/13 Citigroup 03/06/13 Barclays See Street Research during your Free Trial

YEXT Yext $16.62 0.065 (0.39%) 08:01 12/06/19 12/06 08:01 12/06/19 08:01 Recommendations	Yext analyst commentary » Yext price target lowered… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial 03/08/13 Wedge Partners 03/08/13 Credit Suisse 03/06/13 Citigroup 03/06/13 Barclays See Street Research during your Free Trial
POST Post Holdings $106.80 -0.48 (-0.45%) 08:01 12/06/19 12/06 08:01 12/06/19 08:01 Hot Stocks	Post Holdings announces new $400M share repurchase authorization » Post Holdings announced… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in in 9 minutes Get Free Trial 03/08/13 Wedge Partners 03/08/13 Credit Suisse 03/06/13 Citigroup 03/06/13 Barclays See Street Research during your Free Trial
AIN Albany International $81.66 -1.04 (-1.26%) , EADSY Airbus $0.00 (0.00%) 08:01 12/06/19 12/06 08:01 12/06/19 08:01 Hot Stocks	Albany International subsidiary signs two-year research agreement with Airbus » Albany International… AIN Albany International $81.66 -1.04 (-1.26%) EADSY Airbus $0.00 (0.00%) Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial 03/08/13 Wedge Partners 03/08/13 Credit Suisse 03/06/13 Citigroup 03/06/13 Barclays See Street Research during your Free Trial
OKTA Okta $119.18 -2.64 (-2.17%) 08:01 12/06/19 12/06 08:01 12/06/19 08:01 Recommendations	Okta analyst commentary » Okta price target lowered… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in in 9 minutes Get Free Trial 03/08/13 Wedge Partners 03/08/13 Credit Suisse 03/06/13 Citigroup 03/06/13 Barclays See Street Research during your Free Trial	16 Dec
ENB Enbridge $38.50 0.235 (0.61%) 08:00 12/06/19 12/06 08:00 12/06/19 08:00 Conference/Events	Enbridge to host investor meeting » Investor meeting to be… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial 03/08/13 Wedge Partners 03/08/13 Credit Suisse 03/06/13 Citigroup 03/06/13 Barclays See Street Research during your Free Trial	10 Dec

PD PagerDuty $24.99 -0.66 (-2.57%) 08:00 12/06/19 12/06 08:00 12/06/19 08:00 Recommendations	PagerDuty analyst commentary » PagerDuty price target… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in in 9 minutes Get Free Trial 03/08/13 Wedge Partners 03/08/13 Credit Suisse 03/06/13 Citigroup 03/06/13 Barclays See Street Research during your Free Trial
TRXC TransEnterix $0.19 -0.0003 (-0.16%) 07:59 12/06/19 12/06 07:59 12/06/19 07:59 Conference/Events	TransEnterix to hold a webcast » Management hosts a… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial 03/08/13 Wedge Partners 03/08/13 Credit Suisse 03/06/13 Citigroup 03/06/13 Barclays See Street Research during your Free Trial	06 Dec 18 Dec
TDOC Teladoc $79.34 -0.71 (-0.89%) 07:57 12/06/19 12/06 07:57 12/06/19 07:57 Downgrade	Teladoc rating change » Jefferies downgrades… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in in 9 minutes Get Free Trial 03/08/13 Wedge Partners 03/08/13 Credit Suisse 03/06/13 Citigroup 03/06/13 Barclays See Street Research during your Free Trial
ZM Zoom Video $69.73 -0.22 (-0.31%) 07:57 12/06/19 12/06 07:57 12/06/19 07:57 Recommendations	Zoom Video analyst commentary » JPMorgan sees… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial 03/08/13 Wedge Partners 03/08/13 Credit Suisse 03/06/13 Citigroup 03/06/13 Barclays See Street Research during your Free Trial	16 Dec
YEXT Yext $16.62 0.065 (0.39%) 07:55 12/06/19 12/06 07:55 12/06/19 07:55 Recommendations	Yext analyst commentary » Yext price target lowered… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in in 9 minutes Get Free Trial 03/08/13 Wedge Partners 03/08/13 Credit Suisse 03/06/13 Citigroup 03/06/13 Barclays See Street Research during your Free Trial

NDAQ Nasdaq $104.68 -0.49 (-0.47%) 07:55 12/06/19 12/06 07:55 12/06/19 07:55 Conference/Events	House Financial Services Committee to hold a hearing » The Task Force on… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial 03/08/13 Wedge Partners 03/08/13 Credit Suisse 03/06/13 Citigroup 03/06/13 Barclays See Street Research during your Free Trial
AQN Algonquin Power $14.35 0.05 (0.35%) 07:55 12/06/19 12/06 07:55 12/06/19 07:55 Conference/Events	Algonquin Power to host analyst & investor day » Analyst & Investor… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial 03/08/13 Wedge Partners 03/08/13 Credit Suisse 03/06/13 Citigroup 03/06/13 Barclays See Street Research during your Free Trial	06 Dec
IFF International Flavors $141.82 1.8 (1.29%) 07:53 12/06/19 12/06 07:53 12/06/19 07:53 Recommendations	International Flavors analyst commentary » International Flavors… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in in 9 minutes Get Free Trial 03/08/13 Wedge Partners 03/08/13 Credit Suisse 03/06/13 Citigroup 03/06/13 Barclays See Street Research during your Free Trial
COP ConocoPhillips $59.83 -0.8 (-1.32%) 07:53 12/06/19 12/06 07:53 12/06/19 07:53 Initiation	ConocoPhillips initiated » ConocoPhillips initiated… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial 03/08/13 Wedge Partners 03/08/13 Credit Suisse 03/06/13 Citigroup 03/06/13 Barclays See Street Research during your Free Trial
CME CME Group $207.33 2.53 (1.24%) 07:51 12/06/19 12/06 07:51 12/06/19 07:51 Recommendations	CME Group analyst commentary » CME Group price target… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in in 9 minutes Get Free Trial 03/08/13 Wedge Partners 03/08/13 Credit Suisse 03/06/13 Citigroup 03/06/13 Barclays See Street Research during your Free Trial

Events

Earnings calls, analyst events, roadshows and more

Today at 08:30

Employment Situation: Unemployment Rate: November 2019 Government Event
Today at 08:30

Employment Situation: Manufacturing Payrolls M/M: November 2019 Government Event
Today at 08:30

Employment Situation: Participation Rate: November 2019 Government Event
Today at 08:30

Employment Situation: Average Hourly Earnings M/M: November 2019 Government Event
Today at 08:30

Employment Situation: Average Hourly Earnings Y/Y: November 2019 Government Event
Today at 08:30

Employment Situation: Non-Farm Payrolls M/M: November 2019 Government Event
Today at 08:30

Employment Situation: Average Workweek All Employees: November 2019 Government Event
GCO
Today at 08:30

Genesco - GCO Conference Calls
AQN
Today at 08:30

Algonquin Power and Utilities Corp. Firm Sponsored Meetings

, New York, NY
AXP
Today at 08:30

American Express Firm Sponsored Meetings

New York, NY

View All Events »

1 of

Syndicate

This week’s upcoming IPOs and secondary offerings

Priced
Not Priced

Mon	ELF X ELF e.l.f. Beauty Block Trade Managers: Morgan Stanley Priced at: $15.90 3.4M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial AER X AER AerCap Spot Secondary Managers: Citi Priced at: $60.00 4M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial CWEN X CWEN Clearway Energy Spot Secondary Managers: RBC Capital Priced at: $18.70 5.4M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial FSV X FSV FirstService Spot Secondary Managers: BMO Capital & TD Securities Priced at: $92.50 2.165M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial
Tues	ARWR X ARWR Arrowhead Secondary Managers: Goldman Sachs, Jefferies, Piper Jaffray & Cantor Fitzgerald, Baird, B. Riley FBR Priced at: $58.00 4M Shares ASLN X ASLN Aslan Pharmaceuticals Secondary Managers: H.C. Wainwright Priced at: $2.50 5.125M Shares KOD X KOD Kodiak Sciences Secondary Managers: JPMorgan, Goldman Sachs & Jefferies Priced at: $46.00 6M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial VRAY X VRAY ViewRay Secondary Managers: Piper Jaffray Priced at: $3.13 41.55M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial CNNE X CNNE Cannae Holdings Spot Secondary Managers: BofA/Merrill & Stephens Priced at: $33.00 6.5M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial RLMD X RLMD Relmada Therapeutics Spot Secondary Managers: Jefferies, SVB Leerink & Guggenheim Priced at: $30.00 3.333M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial RVNC X RVNC Revance Spot Secondary Managers: Cowen, Piper Jaffray & Stifel Priced at: $17.00 6.5M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial
Wed	LMPX X LMPX LMP Automotive IPO Managers: ThinkEquity Priced at: $5.00 2.3M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial CCC X CCC Clarivate Analytics Secondary Managers: Citi & Goldman Sachs Priced at: $17.25 43.2M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial IMMU X IMMU Immunomedics Secondary Managers: Goldman Sachs, BofA/Merrill, Cowen & Jefferies Priced at: $17.50 14.29M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial TUFN X TUFN Tufin Secondary Managers: JPMorgan, Barclays & Jefferies, Oppenheimer, Baird, Piper Jaffray, Stifel, William Blair Priced at: $17.00 4.28M Shares Special Comments Ratings Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial ARDX X ARDX Ardelyx Spot Secondary Managers: Citi, Cowen, SVB Leerink & Piper Jaffray Priced at: $6.25 20M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial MLND X MLND Millendo Therapeutics Spot Secondary Managers: Citi & SVB Leerink Priced at: $6.00 4.167M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial NJR X NJR New Jersey Resources Spot Secondary Managers: Wells Fargo & JPMorgan, BBNT, TD Securities, Goldman Sachs, Janney Montgomery Scott, Siebert Williams Priced at: $41.25 5.7M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial OMER X OMER Omeros Spot Secondary Managers: Cantor Fitzgerald Priced at: $13.10 3.816M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial RC X RC Ready Capital Spot Secondary Managers: Morgan Stanley, UBS, Wells Fargo & Keefe Bruyette Priced at: $15.58 6M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial WHF X WHF WhiteHorse Finance Spot Secondary Managers: Raymond James, Keefe Bruyette & Deutsche Bank, Ladenburg, Oppenheimer, B. Riley FBR, National Securities Priced at: $13.83 2.25M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial
Thurs	DT X DT Dynatrace Secondary Managers: Goldman Sachs, JPMorgan, Citi, RBC Capital, BofA/Merrill, Barclays, UBS & Jefferies, Canaccord, WBLR BTIG, JMP Securities, KeyBanc, Raymond James, Academy Securities Priced at: $24.75 27.5M Shares Special Comments Ratings Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial EVRI X EVRI Everi Holdings Secondary Managers: Jefferies, Stifel, Craig-Hallum & Raymond James, SunTrust Priced at: $11.25 10M Shares Special Comments Ratings Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial GDS X GDS GDS Holdings Secondary Managers: JPMorgan, RBC Capital & BofA/Merrill, Haitong International Priced at: $45.50 5.49M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial PLUG X PLUG Plug Power Secondary Managers: Morgan Stanley & Barclays Priced at: $2.75 40M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial TTEC X TTEC TTEC Holdings Secondary Managers: BofA/Merrill, Morgan Stanley, Cowen, Craig-Hallum & William Blair, Northland, HSBC Priced at: $36.50 3M Shares Special Comments Ratings Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial EAF X EAF GrafTech Spot Secondary Managers: Morgan Stanley Priced at: $13.25 11.18M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial EVOP X EVOP EVO Payments Spot Secondary Managers: JPMorgan & Barclays Priced at: $27.60 4.5M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial
Fri	No deals

Mon	No deals
Tues	No deals
Wed	No deals
Thurs	CATC X CATC Cambridge Bancorp Spot Secondary Managers: Keefe Bruyette $73.00-74.00 Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial ISEE X ISEE IVERIC bio Spot Secondary Managers: Cowen $4.30 Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial
Fri	No deals

View All Syndicate Announcements »

Natera price target raised to $32 from $27 at JPMorgan

TODAY'S FREE FLY STORIES

Get Full Fly Access